ePrints

A Randomized Controlled Trial of the PanPPAR Agonist Lanifibranor in NASH

Lookup NU author(s): Professor Quentin AnsteeORCiD

Downloads

• Published version [.pdf]

Licence

This is the final published version of an article that has been published in its final definitive form by Massachusetts Medical Society, 2021.

For re-use rights please refer to the publisher's terms and conditions.

Publication metadata

Author(s): Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova M, Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gomez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF

Publication type: Article

Publication status: Published

Journal: New England Journal of Medicine

Year: 2021

Volume: 385

Issue: 17

Pages: 1547-1558

Print publication date: 21/10/2021

Acceptance date: 01/10/2021

Date deposited: 07/10/2021

ISSN (print): 0028-4793

ISSN (electronic): 1533-4406

Publisher: Massachusetts Medical Society

URL: https://doi.org/10.1056/NEJMoa2036205

DOI: 10.1056/NEJMoa2036205

PubMed id: 34670042

Altmetrics

Share